BOSTON, Oct. 13, 2025 (GLOBE NEWSWIRE) -- Pyxis Oncology, Inc. (PYXS), a clinical-stage company developing next-generation therapeutics for difficult-to-treat cancers, announced today that it will ...
Pyxis Oncology (NASDAQ:PYXS), a biopharmaceutical company specializing in the development of antibody-drug conjugates (ADCs) for cancer treatment, has been garnering attention from investors and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback